ISRCTN98642570招募中未知
Surveillance of Tolerability And Treatment Efficacy of Wilate® in von Willebrand?s disease: an observational study
Octapharma GmbH (Germany)0 个研究点目标入组 120 人开始时间: 2012年12月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. The patient suffers from hereditary or acquired von Willebrand's disease and is in need for replacement of coagulation concentrate containing von Willebrand factor (VWF)
- •2. When bleeding history is positive, other causes were excluded
排除标准
- •1. The patient could actually be treated with DDAVP (Desmopressin Acetate)
- •2. The patient has a von Willebrand factor activity over 70 % and there are no findings manifesting the von Willebrand (VWD) diagnosis like
- •2.1. Bleeding pattern compliant with VWD
- •2.2. Positive family history
- •2.3. Mutation analysis
- •2.4. Multimer pattern
研究者
相似试验
已完成
不适用
TREATMENT SEEKING BEHAVIOUR, COMPLIANCE TOTREATMENT AND SELF REPORTED RISK FOR MALARIAAMONG MALARIA AFFECTED INDIVIDUALSCTRI/2013/06/003715JAIJO K JOSE100
进行中（未招募）
不适用
An interventional trial assessing the tolerability and safety of GRAZAX® in adults with grass pollen allergyGrass pollen induced rhinoconjunctivitisMedDRA version: 12.0Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisEUCTR2009-014522-41-ATALK-Abelló A/S100
进行中（未招募）
不适用
An interventional trial assessing the tolerability and safety of GRAZAX® in adults with grass pollen allergyEUCTR2009-014522-41-DEALK-Abelló A/S100
进行中（未招募）
不适用
An interventional trial assessing the tolerability and safety of GRAZAX® in adults with grass pollen allergyGrass pollen induced rhinoconjunctivitisMedDRA version: 12.0Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisEUCTR2009-014522-41-DKALK-Abelló A/S100
招募中
不适用
on-interventional Study to analyse the tolerability and effectiveness of a chemotherapy with taxanes (Eurotere® / Eurotaxel®) on an everyday basis to treat breast cancerC50.9Breast, unspecifiedDRKS00004212apharm GmbH & Co.KG750